Contract 75D30122P15696
Translational Genomics Research Institute · Department Of Health And Human Services · September 28, 2022
Translational Genomics Research Institute was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on September 28, 2022 for $145,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Atlanta, GA. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75D30122P15696
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Equipment And Materials Testing- Instruments And Laboratory Equipment
- Place of performance
- Atlanta, GA
- First action
- September 28, 2022
Description
RUN DATA SAMPLES
Modification timeline
-
September 28, 2022Base award$145.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30122P15696?
Contract 75D30122P15696 is a federal contract awarded to Translational Genomics Research Institute by Department Of Health And Human Services on September 28, 2022 for $145,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75D30122P15696?
Translational Genomics Research Institute won contract 75D30122P15696 from Department Of Health And Human Services.
How much is contract 75D30122P15696 worth?
Contract 75D30122P15696 has obligated $145,000 to date.